Penn Medicine
Help | Search | Site Map | Contact   
faculty photo

Daniel M. Kolansky, MD

Professor of Medicine (Cardiovascular Medicine) at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Perelman School of Medicine, University of Pennsylvania
11th Floor South Tower
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-662-2178
Fax: 215-615-3073
Education:
BA (Human Biology)
Stanford University, 1980.
MD (Medicine)
Yale University, 1984.
Post-Graduate Training
Intern in Medicine, Yale-New Haven Hospital, New Haven, 1984-1985.
Resident in Medicine, Yale-New Haven Hospital, 1985-1987.
Fellow in Cardiovascular Medicine, Yale School of Medicine, 1987-1991.
Fellow in Interventional Cardiology, Yale School of Medicine, 1991-1992.
Certifications
Diplomate, American Board of Internal Medicine, 1987.
Diplomate, Cardiovascular Disease, 1989.
Diplomate, Interventional Cardiology, 1999.
Diplomate, Interventional Cardiology (re-certification), 2009.
Diplomate, Interventional Cardiology (re-certification), 2019.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

therapeutic hypothermia after cardiac arrest, cardiac catheterization and coronary intervention, CAD and familial hyperlipidemia

Description of Clinical Expertise

coronary angioplasty and stenting, cardiac catheterization, treatment of coronary and valvular heart disease, treatment of myocardial infarction

Selected Publications

Smeijer JD, Koomen J, Kohan DE, McMurray JJV, Bakris GL, Correa-Rotter R, Hou F-F, Januzzi JL , Kitzman DW, Kolansky DM, Makino H, Perkovic V, Tobe S, Parving H-H, de Zeeuw D, Heerspink HJL: Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure. J Am Coll Cardiol HF May 2022.

Lee G, Varughese LA, Conway L, Stojinski C, Ashokkumar S, Monono K, Matthai W, Kolansky DM, Giri J, Tuteja S.: Attitudes toward pharmacogenetics in patients undergoing CYP2C19 testing following percutaneous coronary intervention. Per Med. March 2022.

Nathan AS, Geng Z, Eberly LA, Eneanya ND, Dayoub EJ, Khatana SAM, Kolansky DM, Kobayashi TJ, Tuteja S, Fanaroff AC, Giri J, Groeneveld PW.: Identifying Racial, Ethnic, and Socioeconomic Inequities in the Use of Novel P2Y12 Inhibitors After Percutaneous Coronary Intervention. J Invasive Cardiology March 2022.

Hoffecker G, Kanter GP, Xu Y, Matthai W, Kolansky DM, Giri J, Tuteja S.: Interventional cardiologists' attitudes towards pharmacogenetic testing and impact on antiplatelet prescribing decisions. Per Med. January 2022.

Johnson BV, Horton ER, Domenico C, Nathan AS, Fanaroff, AC, Acker, MA, Kolansky DM: Safety of Intravenous Cangrelor Administration for Antiplatelet Bridging in Hospitalized Patients: A Retrospective Study. J Invasive Cardiology 33(12): E998-E1003, December 2021.

Dayoub EJ, Nathan AS, Khatana SAM, Wadhera RK, Kolansky DM, Yeh RW, Giri J, Groeneveld PW.: Trends in Coded Indications for Percutaneous Coronary Interventions in Medicare and the Veterans Affairs After Implementation of Hospital-Level Reporting of Appropriate Use Criteria. Circ Cardiovasc Qual Outcomes 14(4), April 2021.

Adusumalli S, Jolly E, Chokshi NP, Gitelman Y, Rareshide CAL, Kolansky DM, Patel MS.: Referral Rates for Cardiac Rehabilitation Among Eligible Inpatients After Implementation of a Default Opt-Out Decision Pathway in the Electronic Medical Record. JAMA Netw Open 4(1), Jan 2021.

Eberly LA, Kallan MJ, Julien HM, Haynes N, Khatana SAM, Nathan AS, Snider C, Chokshi NP, Eneanya ND, Takvorian SU, Anastos-Wallen R, Chaiyachati K, Ambrose M, O'Quinn R, Seigerman M, Goldberg LR, Leri D, Choi K, Gitelman Y, Kolansky DM, Cappola TP, Ferrari VA, Hanson CW, Deleener ME, Adusumalli S.: Patient Characteristics Associated With Telemedicine Access for Primary and Specialty Ambulatory Care During the COVID-19 Pandemic. JAMA Network Open 3(12): e2031640, December 2020.

Nathan AS, Xiang Q, Wojdyla D, Khatana SAM, Dayoub EJ, Wadhera RK, Bhatt DL, Kolansky DM, Kirtane AJ, Rao SV, Yeh RW, Groeneveld PW, Wang TY, Giri J: Performance of Hospitals When Assessing Disease-Based Mortality Compared With Procedural Mortality for Patients With Acute Myocardial Infarction. JAMA Cardiology 5(7): 765-772, July 2020.

Szerlip M, Feldman DN, Aronow HD, Blankenship JC, Choi JW, Elgendy IY, Elmariah S, Garcia S, Goldstein BH, Herrmann HC, Hira RS, Jaff MR, Kalra A, Kaluski E, Kavinsky CJ, Kolansky DM, Kong DF, Messenger JC, Mukherjee D, Patel RAG, Piana R, Senerth E, Shishehbor M, Singh G, Singh V, Yadav PK, Cox D: SCAI Publications Committee Manual of Standard Operating Procedures. Catheter Cardiovasc Interv Feb 2020.

back to top
Last updated: 01/30/2024
The Trustees of the University of Pennsylvania
 
© The Trustees of the University of Pennsylvania. Site best viewed with a supported browser.
SOM Home International Programs Penn Alumni Clinical Trials Centers and Institutes Departments Faculty Research Education Administration